Enter your login e-mail to the account
Search
Search parameters
Search results
- Current recommendations for the treatment of growth factors granulocytopoiesis
MUDr. Michal Chovanec
(6/2013, Interdisciplinary consilium ) - New trends in metastatic hormone-sensitive prostate cancer treatment
prof. MUDr. Ján Kliment, CSc.
(2/2020, Interdisciplinary consilium ) - Use of biological treatment in oncology
MUDr. Michal Mego, MUDr. Lucia Masárová
(6/2011, Review articles )
- Toxic neuropathy
doc. MUDr. Edvard Ehler, CSc. , MUDr. Jan Latta
(4/2010, Main topic ) - Chronic subdural haematoma associated with advanced malignant tumor
prof. MUDr. Markéta Hermanová, Ph.D., MUDr. Dušan Hrabovský, doc. MUDr. Radim Jančálek, Ph.D., MUDr. Petr Burkoň, Ph.D., doc. MUDr. Jan Chrastina, Ph.D.
(2/2016, Case reports ) - Periferní neuropatie u dětí
MUDr. Josef Kraus, CSc. , MUDr. Ivana Perníková, Marie Brožová
(3/2018, Main topic ) - Peripheral neuropathies in malignancies
prof. MUDr. Zdeněk Ambler, DrSc.
(5/2013, Review articles ) - Chemotherapy-induced polyneuropathy
MUDr. Jana Raputová, MUDr. Eva Vlčková, Ph.D., MUDr. Lenka Šmardová, MUDr. Aneta Rajdová, doc. MUDr. Andrea Janíková, Ph.D.
(1/2017, Main topic )
- New treatment options in hormone-sensitive prostate cancer
MUDr. Otakar Čapoun, Ph.D., FEBU
(5/2019, Review articles ) - Effectiveness and safety of abiraterone acetate treatment for metastatic castration-resistant prostate cancer post-chemotherapy
MUDr. Tomáš Hradec, FEBU, MUDr. Otakar Čapoun, FEBU
(2/2018, Review articles ) - Is age the limitation of metastatic treatment prostate cancer?
MUDr. Jana Katolická, Ph.D.
(5/2018, Review articles ) - HORMONAL MILIEU OF PROSTATE CANCER AND NEW OPTIONS FOR ITS MANAGEMENT
MUDr. Michaela Matoušková
(3/2007, Review articles ) - CHEMOTHERAPY OF HORMONALLY REFRACTORY PROSTATIC CARCINOMA
doc. MUDr. Jozef Mardiak, CSc.
(2/2007, Review articles ) - Have we found an optimal sequence in the treatment of metastatic castrationally-resistant prostate cancer?
MUDr. Tomaš Svoboda, Ph.D.
(1/2019, Review articles )
- Overview of treatment of castration-resistant prostate cancer
MUDr. Jana Obertová
(4/2012, Review articles ) - PHARMACOECONOMICS – ITS POSITION IN DRUG POLICY
prof. RNDr. Viliam Foltán, CSc., Mgr. Veronika Dubajová, PharmDr. Tomáš Tesař, PHD, MBA
(1/2008, Review articles ) - Správa zo 17. celoštátnej pracovnej konferencie SEKCAMA konanej v dňoch 17. a 18. mája 2012
doc. MUDr. Vladimír Bella, PhD.
(4/2012, Events ) - PHARMACOECONOMIC EVALUATION OF DOCETAXEL IN INDUCTION CHEMOTHERAPY OF LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN)
PharmDr. Dominik Tomek, MPH, MUDr. Milan jamárik
(1/2008, Review articles ) - The growth factors in oncology
MUDr. Ján Gyárfáš
(4/2012, Main topic ) - Targeted biological therapy for lung cancer – current status and perspectives
doc. MUDr. Peter Beržinec, CSc.
(1/2011, Review articles ) - Biological treatment of the small cell lung cancer
MUDr. Peter Kasan
(1/2007, Review articles ) - Biologic and targeted therapy for urogenital maliginities
MUDr. Mária Rečková
(1/2011, Review articles ) - Castration resistant prostate cancer in the year 2013
doc. MUDr. Jozef Marenčák, PhD.
(3/2013, Review articles ) - Chemotherapy of hormonally refractory prostatic carcinoma
doc. MUDr. Jozef Mardiak, CSc.
(1/2007, Review articles ) - Lung cancer in elderly
doc. MUDr. Mária Wagnerová, CSc.
(1/2007, Review articles ) - Capecitabine and its role in the treatment of advanced HER2 positive breast cancer
doc. MUDr. Igor Andrašina, CSc., MUDr. Radovan Barilla, PhD.
(1/2011, Review articles ) - Radium 223Ra in the treatment of bone malignancies
prof. MUDr. Ján Kliment, CSc., MUDr. Hubert Poláček, Ph.D., doc. MUDr. Ivan Režňák, CSc.
(5/2016, Review articles ) - Anti-tumor therapy in patients with liver insufficiency
MUDr. Michal Mego, PhD., MUDr. Ján Rajec, PhD.
(1/2011, Review articles ) - GERIATRIC PATIENTS WITH ADVANCED CANCER IN 2 000 WORDS
doc. MUDr. Mária Wagnerová, CSc.
(2/2006, Review articles ) - Správa z X. Košických chemoterapeutických dní, 23. – 24. november 2006
MUDr. Radovan Barilla
(1/2007, Events ) - CURRENT ALTERNATIVES FOR SECOND LINE CHEMOTHERAPY OF RECURRENT CIS-PLATIN REFRACTORY EPITHELIAL OVARIAN CANCER
MUDr. Radovan Barilla
(2/2006, Review articles ) - Publikujeme v zahraničí
(1/2011, Information & comments ) - CARDIOVASCULAR COMPLICATIONS OF SELECTED ANTICANCER AGENTS – NEW INSIGHTS INTO PATHOGENESIS AND DIAGNOSTICS
doc. MUDr. Beáta Mladosievičová, CSc., MUDr. Silvia Cingelová
(2/2008, Review articles ) - Novinky z ASCO 2006
MUDr. Tomáš Šálek, MUDr. Radovan Barilla,
(3/2006, Events ) - An update in breast cancer treatment
MUDr. Markéta Palácová
(4/2007, Review articles ) - Optimal timing of chemotherapy and radiotherapy for stage III non-small cell lung cancer
doc. MUDr. Peter Beržinec, CSc., h. doc. MUDr. Elena Bolješíková, CSc.
(4/2007, Review articles ) - Anthracyclines in treating metastatic breast cancer
MUDr. Katarína Petráková
(3/2014, Review articles ) - Proper selection of patients for Radium 223 and its role in metastatic castration-resistant prostate cancer treatment
JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M., MUDr. Ján Slopovský
(2/2021, Review articles ) - Diskusné fórum onkológov
(1/2009, Discussion forum ) - Publikujeme v zahraničí
(3/2014, Information & comments ) - 18F-choline PET/CT in evaluation of therapeutic response of castration-resistant prostate cancer
Doc. MUDr. Soňa Balogová, PhD., MUDr. Lucia Noskovičová, MUDr. Lucia Kaliská FEBMN , MUDr. Marika Vereb, FEBMN, MUDr. Marek Bartovic
(3/2015, Review articles ) - Treatment of bone metastases in castration resistant prostate cancer – current view
doc. MUDr. Jozef Marenčák, PhD.
(3/2015, Review articles ) - How to improve the first line treatment of NSCLC with EGFR mutation?
doc. MUDr. Peter Beržinec, CSc.
(6/2016, Review articles ) - Immune checkpoint inhibitors in non-small cell lung cancer therapy
MUDr. Mária Černá, CSc.
(6/2015, Main topic ) - Treatment of ALK-rearranged non-small cell lung cancer
MUDr. Zuzana Pribulová
(6/2015, Main topic ) - Current position of vinorelbine within complex breast cancer treatment
MUDr. Silvia Jurišová, MUDr. Miroslava Malejčíková
(6/2016, Drugs & drug classes ) - Inflammatory breast cancer
doc. MUDr. Mária Wagnerová, CSc.
(2/2012, Main topic ) - Clinical significance of PD-L1 immune check-point measurement
MUDr. Peter Kasan
(2/2017, Drugs & drug classes ) - Chemotherapy for carcinoma of stomach
MUDr. Tomáš Šálek
(3/2011, Review articles ) - Primary treatment of metastatic prostate cancer
MUDr. Matej Hrnčár, MUDr. Marek Lafférs, MUDr. Jozef Breznický, MUDr. Ján Šulgan, MUDr. Juraj Sokol, PhD., PhD., MUDr. Juraj Chudej, PhD.
(5/2017, Review articles ) - Cancer drug consumption in Slovakia and its economic impact – development and trends
prof. RNDr. Viliam Foltán, CSc., PharmDr. Veronika Dubajová, Mgr. Katarína Gatialová , Mgr. Katarína Bellová
(3/2011, Review articles ) - Effective treatment of lung adenocarcinoma with target therapy – case report
MUDr. Gabriela Chowaniecová
(5/2017, Original articles & case reports ) - Lutetium-177-PSMA in therapy of metastatic prostate cancer
MUDr. Eva Takácsová, PhD.
(4/2022, Main topic ) - Specifics of treatment of breast cancers in women older than 70 years
doc. MUDr. Mária Wagnerová, CSc.
(5/2012, Main topic ) - Nano-particle nab-paclitaxel in treatment of metastatic breast cancer
MUDr. Jozef Dolinský, MUDr. Radovan Barilla, PhD.
(4/2011, Review articles ) - GASTRIC CANCER
MUDr. Tomáš Šálek
(2/2007, Review articles ) - Indications and options for radiotherapy and chemoradiotherapy in the treatment of head and neck cancer
MUDr. Viktor Rosenberg
(4/2011, Review articles ) - Treatment of advanced metastatic lung cancer in older patients
doc. MUDr. Peter Beržinec, CSc.
(5/2012, Main topic ) - Comprehensive treatment of epithelial ovarian cancer
MUDr. Tibor Packaň, PhD.
(5/2011, Review articles ) - Review on castrate-resistant prostate carcinoma systemic therapy
Doc. JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M.
(4/2023, Main topic ) - Publikujeme v zahraničí
(5/2011, Information & comments ) - Optimization of radiotherapy of high-risk prostate cancer
doc. MUDr. Pavol Dubinský, PhD., MHA
(5/2019, Main topic ) - A comprehensive view of the treatment of metastatic hormone sensitive prostate cancer
prof. MUDr. Ján Kliment, CSc., MUDr. Ing. Monika Kuzma, MBA
(5/2019, Main topic ) - Castration resistant prostate cancer – something new in the year 2014?
doc. MUDr. Jozef Marenčák, PhD.
(4/2014, Main topic ) - Radiotherapy and the early radiation-induced skin changes
Mgr. Nadežda Višňovcová, doc. MUDr. Ingrid Tonhajzerová, PhD., Ing. Viera Jakušová, PhD., MPH, doc. Ing. Helena Baráni, CSc., prof. MUDr. Ján Jakuš, DrSc.
(5/2010, Original articles & case reports ) - Systemic treatment of cancer of unknown primary origin
MUDr. Mária Rečková
(4/2013, Main topic ) - Nab-technologies, nab-paclitaxel and new treatment possibilities in the treatment of selected oncology diseases
MUDr. Tomáš Šálek, MUDr. Radovan Barilla, PhD.
(4/2014, Review articles ) - Správy z podujatia ASCO Chicago 2014
prof. MUDr. Stanislav Špánik, CSc., MUDr. Mária Rečková, MUDr. Patrik Palacka, PhD. MPH, MBA
(4/2014, Events ) - Pokrok v imunoterapii malígneho melanómu a karcinómu pľúc inhibítormi imunitných kontrolných bodov
MUDr. Róbert Godál
(2/2018, Main topic ) - XLIII. bratislavských onkologických dní – správa z podujatia
MUDr. Oľga Szegheőová
(4/2006, Events ) - Nežiaduce účinky imunoterapie a ich manažment
MUDr. Jaroslava Lešková
(2/2018, Main topic ) - Použitie rastových faktorov myelopoézy v profylaxii febrilnej neutropénie
MUDr. Juraj Chudej, PhD., MUDr. Matej Hrnčár, MUDr. Juraj Sokol, PhD., MUDr. Ivana Plameňová, PhD., MUDr. Ľubica Váleková, PhD., Prof. MUDr. Ján Staško, PhD.
(2/2018, Review articles ) - Breast cancers in erderly women
doc. MUDr. Mária Wagnerová, CSc., doc. MUDr. Alexander Berč, CSc.
(2/2009, Review articles ) - Cardiotoxicity of drugs used in adjuvant therapy of breast cancer
doc. MUDr. Beáta Mladosievičová, CSc., MUDr. Katarína Ševčíková
(2/2009, Review articles ) - Eribulin in treatment of breast cancer
doc. MUDr. Mária Wagnerová, CSc., MUDr. Hana Garanová
(1/2015, Drugs & drug classes ) - Favourable therapeutic response of enzalutamide in patient with metastatic castration resistant prostate cancer
MUDr. Martin Romančík, PhD., MPH
(S1/2019, Case reports ) - Enzalutamide in the treatment of metastatic castration-resistant prostate cancer
MUDr. Andrej Rosík, MUDr. Ladislav Slobodník
(S1/2019, Case reports ) - Pegylated liposomal doxorubicin in the treatment of recurent ovarian cancer
doc. MUDr. Lýdia Heľpianska, CSc.
(4/2009, Review articles ) - Current indications for pemetrexed in the treatment of non-small cell lung cancer
doc. MUDr. Peter Beržinec, CSc.
(4/2009, Review articles ) - Chemotherapy of lung cancer – what is new in 2009?
doc. MUDr. Peter Beržinec, CSc.
(1/2010, Review articles ) - Aktuálne z ASCO 2009
doc. MUDr. Peter Beržinec, CSc., prof. MUDr. Stanislav Špánik, CSc., MUDr. Marián Streško
(4/2009, Events ) - A new trend in targeted (biologic) therapy of non-small cell lung cancer in the 2009 – maintenance therapy
MUDr. Peter Kasan
(1/2010, Review articles ) - Systemic treatment of advanced, persistent or recurrent cervical cancer
MUDr. Mária Rečková
(4/2015, Review articles ) - Lipegfilgrastim − new drug form similar to filgrastim in treatment of neutropenia of oncologic patients
prof. PharmDr. Ján Kyselovič, CSc., PharmDr. Andrea Gažová, PhD.
(4/2015, Drugs & drug classes ) - Enzalutamide in treatment of the metastatic castration resistant prostate cancer
Doc. MUDr. Jozef Marenčák, PhD.
(6/2017, Drugs & drug classes ) - Antineoplastic treatment of patients with renal insufficency
MUDr. Ján Rajec, PhD., doc. MUDr. Michal Mego, PhD.
(2/2011, Review articles ) - WHAT ARE WE ABLE TO ACHIEVE IN THE TREATMENT OF METASTATIC NON-SMALL CELL LUNG CANCER TODAY?
doc. MUDr. Peter Beržinec, CSc.
(3/2008, Original articles ) - Systemic therapy of pancreatic cancer
MUDr. Tomáš Šálek, MUDr. Iveta Andrezálová Vochyanová
(3/2012, Main topic ) - Systemic therapy of biliary tract cancers
MUDr. Tomáš Šálek, MUDr. Zuzana Hlavatá, MUDr. Štefan Pörsök, PhD., MUDr. Veronika Švábová, PhD.
(3/2012, Main topic ) - Immunotherapy for lung cancer
doc. MUDr. Peter Beržinec, CSc.
(4/2016, Main topic ) - 11 11TH TH CENTRAL EUROPEAN LUNG CANCER CONFERENCE
doc. MUDr. Peter Beržinec, CSc.
(3/2008, Events ) - Rare lung cancers
doc. MUDr. Peter Beržinec, CSc.
(2/2013, Main topic ) - Targeted terapy of gastric cancer
MUDr. Vanda Ušáková, PhD.
(5/2014, Review articles ) - Správa z podujatia ASCO Chicago 2012
(3/2012, Events ) - Správa z Best of ASCO® Slovakia 2016
MUDr. Mária Rečková
(4/2016, Events ) - Ipilimumab – new drug, new experience
MUDr. Zuzana Hlavatá, PhD.
(5/2013, Original articles & case reports ) - Vinflunine in the metastatic urothelial carcinoma treatment after disease progression on gemcitabine with cisplatin – case-report
doc. MUDr. Jozef Mardiak, CSc., mim. prof., doc. MUDr. Michal Mego, PhD., MUDr. Štefánia Lišková, MUDr. Patrik Palacka, PhD., MPH, MBA, MUDr. Jana Obertová, PhD.
(5/2013, Original articles & case reports ) - Crizotinib – a new molecule in the treatment of lung cancer?
MUDr. Lenka Medvecová
(1/2012, Drugs & drug classes ) - Správa z Best of ASCO® Slovakia 2011
MUDr. Mária Rečková
(1/2012, Events ) - Position of surgery, adjuvant and neoadjuvant therapy in gastric cancer
doc. MUDr. Daniel Pinďák, PhD., MUDr. Jozef Dolník, MUDr. Štefan Pörsök, PhD., MUDr. Silvia Jurišová, MUDr. Robert Duchoň, PhD., MUDr. Jana Pavlendová
(5/2015, Main topic ) - ABC transporters: multidrug resistance and different types of human diseases
prof. MUDr. Stanislav Špánik, CSc., doc. MUDr. Viera Lehotská, PhD., MUDr. Katarína Rauová, RNDr. Eva Weismanová, PhD., RNDr. Ľubomír Horváth, CSc., Mgr. Ján Markus, PhD., MUDr. Ladislav Sopko
(1/2012, Review articles ) - New possibilities and view for treatment of castration resistent prostate cancer
doc. MUDr. Igor Andrašina, CSc., MUDr. Radovan Barilla, PhD.
(1/2012, Review articles ) - 12 12TH TH WORLD CONFERENCE ON LUNG CANCER, WORLD CONFERENCE ON LUNG CANCER,
doc. MUDr. Peter Beržinec, CSc.
(5/2007, Events ) - ODPORÚČANIA SLOVENSKEJ ONKOLOGICKEJ SPOLOČNOSTI SLS PRE ANTIEMETICKÚ LIEČBU V ONKOLÓGII
Slovenská onkologická spoločnosť
(6/2008, Information & comments ) - Antiemetic therapy – what has brought the last decade?
MUDr. Jana Obertová
(6/2010, Review articles ) - Neuropathic pain – new trends of pharmacotherapy
MUDr. Ľubomíra Nemčíková
(6/2010, Review articles ) - Metastatic prostate cancer - new therapeutical approaches
MUDr. Patrik Palacka, PhD., MPH, MBA, Mgr. Soňa Herudová
(2/2015, Review articles ) - Chemotherapy in combination with radiotherapy in locally advanced head and neck carcinoma
doc. MUDr. Pavol Dubinský, PhD.
(2/2015, Review articles ) - Antitumor immunity
MUDr. Ján Lakota, CSc., MUDr. Milan Žuffa, CSc.
(2/2015, Review articles ) - Pain in cancer survivors
Prof. MUDr. Beata Mladosievičová, PhD.
(1/2017, Main topic ) - ESMO 2010 – kongres, ktorý prelomil rekordy
doc. MUDr. Peter Beržinec, CSc.
(6/2010, Events ) - Novinky z American Society of Clinical Oncology 2010
doc. MUDr. Peter Beržinec, CSc., MUDr. Tomáš Šálek, prof. MUDr. Stanislav Špánik, CSc., MUDr. Mária Rečková
(4/2010, Events ) - VI. Bardejovské onkologické dni
MUDr. Jozef Chovanec
(4/2010, Events ) - Správa z Best of ASCO® Slovakia 2012
MUDr. Mária Rečková
(6/2012, Events ) - 7. bardejovské onkologické dni
MUDr. Jozef Chovanec
(6/2012, Events ) - Actual therapeutic strategy of patients with non small cell lung cancer with EML4-ALK rearrangement
MUDr. Juraj Mazal, MUDr. Michal Urda, RNDr. Anna Farkašová, PhD.
(1/2017, Review articles ) - 17. svetová konferencia o karcinóme pľúc
Doc. MUDr. Peter Beržinec, CSc.
(1/2017, Events ) - Chemotherapy of hormone refractory prostate cancer
MUDr. Marta Škultétyová, MUDr. Andrea Mocná
(5/2009, Review articles ) - First-line treatment of metastatic castration-sensitive prostate cancer
JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M., MUDr. Ján Slopovský
(3/2022, Review articles ) - Adjuvant therapy of prostate cancer
MUDr. Pavol Dubinský, PhD.
(5/2009, Review articles ) - Abiraterone in treatment of metastatic castrate resistant prostate cancer
prof. MUDr. Ján Kliment, CSc.
(2/2014, Drugs & drug classes ) - Treatment metastatic gastric cancer
MUDr. Vanda Ušáková, PhD.
(1/2018, Review articles ) - INTERNATIONAL MEETING ON INNOVATIVE APPROACHES IN HEAD AND NECK ONCOLOGY,BARCELONA 2007
MUDr. Tibor Barta, PhD.
(3/2007, Events ) - Metronomic chemotherapy in breast cancer
MUDr. Bibiána Vertáková Krakovská, PhD.
(1/2018, Review articles ) - Management ovarian brain metastasis
MUDr. Marián Streško
(3/2009, Original articles & case reports ) - Nintendanib – new triple inhibitor of angiokinases in 2nd line of NSCLC
MUDr. Zuzana Pribulová
(2/2016, Drugs & drug classes ) - ASCO 2008, SPRÁVA Z MEDZINÁRODNÉHO STRETNUTIA ONKOLÓGOV
MUDr. Marcela Tkáčová
(4/2008, Events ) - NEOADJUVANT SYSTEMIC TREATMENT OF OPERABLE BREAST CANCER
prof. MUDr. Stanislav Špánik, CSc.
(3/2006, Review articles ) - CHEMOTHERAPY OF THE HEAD AND NECK TUMOR´S
MUDr. Dagmar Sorkovská
(3/2007, Review articles - treatment ) - Management of skin toxicities associated with epidermal growth factor inhibitor cetuximab in combination with chemotherapy or radiotherapy
MUDr. Katarína Poláková
(6/2011, Review articles ) - SIGNIFICANCE OF GENE EXPRESSION PROFILING FOR PREDICTION OF PROGNOSIS AND THERAPY RESPONSE IN BREAST CARCINOMA
prof. MUDr. Lukáš Plank, CSc., doc. MUDr. Karol Kajo, PhD.
(4/2008, Review articles ) - 2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer
Editor rubriky: doc. MUDr. Peter Beržinec, CSc.
(6/2011, Information & comments ) - Glukokortikoidy v liečbe kastračne-rezistentného karcinómu prostaty a mechanizmy rezistencie na androgénnu blokádu
JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M.
(4/2018, Review articles ) - Androgen deprivation therapy and radiotherapy of prostate cancer
doc. MUDr. Pavol Dubinský, PhD.
(5/2018, Review articles )
- CHEMOTHERAPY OF THE HEAD AND NECK TUMOR´S
MUDr. Dagmar Sorkovská
(3-4/2007, clearly )
- Nové liečivá v EÚ registrované v roku 2011 (I.)
PharmDr. Peter Stanko
(1/2012, New drugs )